formulation


Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
References in periodicals archive ?
3 that all the samples, except for Formulation 2 appear to wet the surface of the polymer coating.
Opioid analgesics sold in Japan by Daiichi Sankyo comprise the hydromorphone hydrochloride formulations Narusus[R] Tablets (extended release formulation), Narurapid[R] Tablets (immediate release formulation) and Naruvein[R] Injection (injection formulation), the oxycodone hydrochloride formulations OxycodoneExtended Release Tablets "Daiichi Sankyo" (extended release formulation) and OxycodoneTablets "Daiichi Sankyo" (immediate release formulation) and Oxycodone Injections "Daiichi Sankyo" that has just been launched, as well as the fentanyl citrate tape formulation Fentanyl Citrate Tape for 1 day "Daiichi Sankyo" (transdermal absorption formulation).
"Until now, formulating large biological active pharmaceutical ingredients such as proteins and large peptides into long-acting sustained release formulations has been difficult, if not impossible," said Andrew Bulpin, head of Process Solutions at Millipore-Sigma.
Ref: "Threats to global antimicrobial resistance control: Centrally approved and unapproved antibiotic formulations sold in India." Patricia McGettigan, Peter Roderick, Abhay Kadam, and Allyson Pollock.
Blood sampling of rats in Group 1 was at 30 min intervals (based on half-life of immediate release formulation) from 21:00 h to 22:30 h GMT, and at 01.30 h GMT.
During first treatment period, after an overnight fasting, each volunteer of group A was given a dose of 500 mg of clarithromycin of test formulation and each volunteer of group B was given a dose of 500 mg of clarithromycin of reference formulation (Klaricid(r)) with 240 ml of water.
Another issue to consider is whether the formulation base is similar.
The US Food and Drug Administration has issued the clinical hold decision following a review of three mild-to-moderate thrombotic events in healthy volunteers receiving the IV formulation of SCY-078 at the highest doses and highest concentrations in a Phase 1 study.
The pH of the optimized formulation was measured by using a pH meter (Mettler-Toledo, Switzerland).
The "Formulating with Fascinating Silicone" tool will help customers accelerate development and marketing of their pharmaceutical and OTC solutions by streamlining the formulation process.